LEGACY

The primary aim of the LEGACy project is to improve gastric cancer outcomes by applying personalized medicine at the three levels of prevention in EU and CELAC populations... The CELAC and European consortium for a personalized medicine approach to Gastric Cancer (LEGACy) is a partnership between 11 organisations from Argentina, Belgium, Chile, Germany, Mexico, The Netherlands, Paraguay, Portugal and Spain.